Insulin transiently increases tau phosphorylation: Involvement of glycogen synthase kinase-3β and Fyn tyrosine kinase

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 576-584

  Lesort, Mathieu ^a   Jope, Richard S ^a   Johnson, Gail V W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Fyn; Glycogen synthase kinase 3 ; Insulin; Phosphorylation; Tau

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE; PROTEIN TYROSINE KINASE; RECOMBINANT HUMAN INSULIN; SOMATOMEDIN C; TAU PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NERVE CELL PLASTICITY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MICROTUBULE-ASSOCIATED PROTEINS; NEUROBLASTOMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; TAU PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032955426     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720576.x     Document Type: Article

References (50)

1. Bennett G. S., Laskowska D., and DiLullo C. (1991) Lithium chloride inhibits the phosphorylation of newly synthesized neurofilament protein, NF-M, in cultured chick sensory neurons. J. Neurochem. 57, 120-129.
2. Bixby J. L. and Jhabvala P. (1993) Tyrosine phosphorylation in early embryonic growth cones. J. Neurosci. 13, 3421-3432.
3. Black M. M., Slaughter T., Moshiach S., Obrocka M., and Fischer I. (1996) Tau is enriched on dynamic microtubules in the distal region of growing axons. J. Neurosci. 16, 3601-3619.
4. Boyle W. J., Smeal T., Defize L. H., Angel P., Woodgett J. R., Karin M., and Hunter T. (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64, 573-584.
5. Brandt R., Leger J., and Lee G. (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131, 1327-1340.
6. Carmel G., Mager E. M., Binder L. I., and Kuret J. (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271, 32789-32795.
7. Cobb M. H. and Goldsmith E. J. (1995) How MAP kinases are regulated. J. Biol. Chem. 270, 14843-14846.
8. Craft S., Newcomer J., Kanne S., Dagogo-Jack S., Cryer P., Sheline Y., Luby J., Dagogo-Jack A., and Alderson A. (1996) Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging 17, 123-130.
9. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., and Hemmings B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
10. Cross D. A., Watt P. W., Shaw M., van der Kaay J., Downes C. P., Holder J. C., and Cohen P. (1997) Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett. 406, 211-215.
11. DiTella M., Feiguin F., Morfini G., and Caceres A. (1994) Microfilament-associated growth cone component depends upon Tau for its intracellular localization. Cell Motil. Cytoskeleton 29, 117-130.
12. Eldar-Finkelman H., Seger R., Vandenheede J. R., and Krebs E. G. (1995) Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J. Biol. Chem. 270, 987-990.
13. Fiol C. J., Williams J. S., Chou C. H., Wang Q. M., Roach P. J., and Andrisani O. M. (1994) A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J. Biol. Chem. 269, 32187-32193.
14. Fleming L. M., Weisgraber K. H., Strittmatter W. J., Troncoso J. C., and Johnson G. V. (1996) Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp. Neurol. 138, 252-260.
15. Goedert M., Spillantini M. G., Potier M. C., Ulrich J., and Crowther R. A. (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 87, 393-399.
16. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P., and Anderton B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localization of the kinase. Neurosci. Lett. 147, 58-62.
17. Hemmings B. A., Aitken A., Cohen P., Rymond M., and Hofmann F. (1982) Phosphorylation of the type-II regulatory subunit of cyclic-AMP-dependent protein kinase by glycogen synthase kinase 3 and glycogen synthase kinase 5. Eur. J. Biochem. 127, 473-481.
18. Hong M. and Lee V. M. (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272, 19547-19553.
19. Hong M., Chen D. C., Klein P. S., and Lee V. M. (1997) Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272, 25326-25332.
20. Hughes K., Pulverer B. J., Theocharous P., and Woodgett J. R. (1992) Baculovirus-mediated expression and characterization of rat glycogen synthase kinase-3 beta, the mammalian homologue of the Drosophila melanogaster zeste-white 3sgg homeotic gene product. Eur. J. Biochem. 203, 305-311.
21. Hughes K., Nikolakaki E., Plyte S. E., Totty N. F., and Woodgett J. R. (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803-808.
22. Illenberger S., Zheng-Fischhofer Q., Preuss U., Stamer K., Baumann K., Trinczek B., Biernat J., Godemann R., Mandelkow E.-M., and Mandelkow E. (1998) The endogenous and cell cycle dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol. Biol. Cell 9, 1495-1512.
23. Ishiguro K., Takamatsu M., Tomizawa K., Omori A., Takahashi M., Arioka M., Uchida T., and Imahori K. (1992) Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J. Biol. Chem. 267, 10897-10901.
24. Johnson G. V. W., Seubert P., Cox T. M., Motter R., Brown J. P., and Galasko D. (1997) The τ protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68, 430-433.
25. Kojima N., Wang J., Mansuy I. M., Grant S. G., Mayford M., and Kandel E. R. (1997) Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. Proc. Natl. Acad. Sci. USA 94, 4761-4765.
26. Kosik K. S. (1993) The molecular and cellular biology of tau. Brain Pathol. 3, 39-43.
27. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C. Freed R., Liosatos M., Morgan T. E., Rozovsky I., Trommer B., Viola K. L., Wals P., Zhang C., Finch C. E., and Krafft G. A. (1998) Diffusible, nonfibrillar ligands derived from Aβ 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448-6453.
28. Leventhal P. S., Shelden E. A., Kim B., and Feldman E. L. (1997) Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-l-stimulated lamellipodial advance. J. Biol. Chem. 272, 5214-5218.
29. Lindwall G. and Cole R. D. (1984) Phosphorylation affects the ability of tau protein to promote microtubule assembly. J. Biol. Chem. 259, 5301-5305.
30. Lovestone S., Reynolds C. H., Latimer D., Davis D. R., Anderton B. H., Gallo J. M., Hanger D., Mulot S., Marquardt B., Stabel S., et al. (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4, 1077-1086.
31. Mandelkow E. M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenhcede J. R., and Mandelkow E. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 314, 315-321.
32. Mandell J. W. and Banker G. A. (1996) A spatial gradient of tau protein phosphorylation in nascent axons. J. Neurosci. 16, 5727-5740.
33. Murai H., Okazaki M., and Kikuchi A. (1996) Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation. FEBS Lett. 392, 153-160.
34. Nikolakaki E., Coffer P. J., Hemelsoet R., Woodgett J. R., and Defize L. H. (1993) Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene 8, 833-840.
35. Plyte S. E., Hughes K., Nikolakaki E., Pulverer B. J., and Woodgett J. R. (1992) Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta 1114, 147-162.
36. Pope W., Enam S. A., Bawa N., Miller B. E., Ghanbari H. A., and Klein W. L. (1993) Phosphorylated tau epitope of Alzheimer's disease is coupled to axon development in the avian central nervous system. Exp. Neurol. 120, 106-113.
37. Shirazi S. K. and Wood J. G. (1993) The protein tyrosine kinase, fyn, in Alzheimer's disease pathology. Neurorepori 4, 435-437.
38. Stambolic V. and Woodgett J. R. (1994) Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem. J. 303, 701-704.
39. Stambolic V., Ruel L., and Woodgett J. R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells. Curr. Biol. 6, 1664-1668.
40. Sun X. J., Pons S., Asano T., Myers M. G. Jr., Glasheen E., and White M. F. (1996) The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271, 10583-10587.
41. Sutherland C., Leighton I. A., and Cohen P. (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signaling. Biochem. J. 296, 15-19.
42. Szendrei G. I., Lee V. M., and Otvos L. Jr. (1993) Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location. J. Neurosci. Res. 34, 243-249.
43. Takahashi M., Tomizawa K., Kato R., Sato K., Uchida T., Fujita S. C., and Imahori K. (1994) Localization and developmental changes of r protein kinase I/glycogen synthase kinase-3β in rat brain. J. Neurochem. 63, 245-255.
44. Villa-Moruzzi E. (1989) Stimulation of FA and phosphatase-1 activities by insulin in 3T3-L1 cells. FEBS Lett. 258, 208-210.
45. Wallace W. C., Akar C. A., Lyons W. E., Kole H. K., Egan J. M., and Wolozin B. (1997) Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. Brain Res. Mol. Brain Res. 52, 213-227.
46. Wang Q. M., Fiol C. J., DePaoli-Roach A. A., and Roach P. J. (1994) Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 269, 14566-14574.
47. Woodgett J. R. (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431-2438.
48. Yang S. D., Chou C. K., Huang M., Song J. S., and Chen H. C. (1989a) Epidermal growth factor induces activation of protein kinase FA and ATP·Mg-dependent protein phosphatase in A431 cells. J. Biol. Chem. 264, 5407-5411.
49. Yang S. D., Ho L. T., Fung T. J., and Yu J. S. (1989b) Insulin induces activation of kinase FA in membranes and thereby promotes activation of ATP·Mg-dependent phosphatase in adipocytes. Biochem. Biophys. Res. Commun. 158, 762-768.
50. Yang S. D., Song J. S., Hsieh Y. T., Liu H. W., and Chan W. H. (1992) Identification of the ATP·Mg-dependent protein phosphatase activator (FA) as a synapsin I kinase that inhibits cross-linking of synapsin I with brain microtubules. J. Protein Chem. 11, 539-546.